Celagenex
Celagenex is a research organization focused on developing therapeutic approaches that modulate cellular and mitochondrial metabolism using endogenous biological metabolites combined with bioavailability enhancers. The organization pursues preclinical and clinical studies across neurological, metabolic and organ-specific indications, holds an intellectual property portfolio of issued/filed patents, and engages in licensing and partnership opportunities.
Industries
Nr. of Employees
small (1-50)
Celagenex
Celagenex LLC, 6113 Alpine Blue DR, San Ramon, CA 94582, USA
Patents
Synergistic nutritional compositions for treating neurocognitive disorders
US-12336972-B2
View DetailsSynergistic nutritional compositions for treating cerebrovascular diseases
US-11925195-B2
View DetailsSynergistic medicinal compositions for treating dysfunctional D-serine signaling
US-11376277-B2
View Details
Synergistic nutritional compositions for treating neurocognitive disorders
US-12336972-B2
View DetailsSynergistic nutritional compositions for treating cerebrovascular diseases
US-11925195-B2
View DetailsSynergistic medicinal compositions for treating dysfunctional D-serine signaling
US-11376277-B2
View DetailsProducts
Therapeutic candidates targeting cellular and mitochondrial metabolism
Candidate therapies designed to modulate cellular metabolism and mitochondrial function for indications including neurological injury, metabolic syndrome, cardiac and hepatic dysfunction, and reproductive implantation support.
Therapeutic candidates targeting cellular and mitochondrial metabolism
Candidate therapies designed to modulate cellular metabolism and mitochondrial function for indications including neurological injury, metabolic syndrome, cardiac and hepatic dysfunction, and reproductive implantation support.
Services
Evaluation and engagement for licensing opportunities, commercial partnerships and enquiries related to therapies, drug delivery technologies, services and manufacturing capabilities.
Collaboration on preclinical and clinical studies to validate metabolite-based therapeutic approaches across neurological, metabolic and organ-specific indications.
Evaluation and engagement for licensing opportunities, commercial partnerships and enquiries related to therapies, drug delivery technologies, services and manufacturing capabilities.
Collaboration on preclinical and clinical studies to validate metabolite-based therapeutic approaches across neurological, metabolic and organ-specific indications.
Expertise Areas
- Cellular and mitochondrial metabolism modulation
- Neuroregeneration and neuroprotection
- Mitochondria-targeted therapeutics
- Metabolic syndrome and endocrinology-related therapeutics
Key Technologies
- Metabolite-based therapeutics
- Bioavailability enhancement formulations
- Mitochondria-targeted therapy approaches
- NAD+ modulation strategies
News & Updates
The company reports an intellectual property portfolio with thirteen issued and/or filed patents and patents pending globally.
The company reports an intellectual property portfolio with thirteen issued and/or filed patents and patents pending globally.